Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB01149_nanopub.RADtUrEJa5dWbvdtjny71PGIvTJzLLp11vCYZxhQj1TOI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB01149 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB01149 label "DDI between Trazodone and Nefazodone - Increased risk of serotonin syndrome. The CYP3A4 inhibitor, Nefazodone, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for symtpoms of sertonin syndrome and changes in Trazodone efficacy/toxicity if Nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB01149]" assertion.
- drugbank_resource:DB00656_DB01149 identifier "drugbank_resource:DB00656_DB01149" assertion.
- drugbank_resource:DB00656_DB01149 title "DDI between Trazodone and Nefazodone - Increased risk of serotonin syndrome. The CYP3A4 inhibitor, Nefazodone, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for symtpoms of sertonin syndrome and changes in Trazodone efficacy/toxicity if Nefazodone is initiated, discontinued or dose changed." assertion.
- drugbank:DB01149 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01149 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01149 assertion.